Bunker Hill Community College Boston, MA Mar 2012 to May 2012 Volunteer Income Tax AssistantJ & P Retail Chain Store Hong Kong Hong Kong, Hong Kong Island Mar 1997 to Dec 2001 Accountant
Education:
Bunker Hill Community College Boston Boston, MA Jun 2012 A.S. in Business Administration, Finance OptionBunker Hill Community College Boston Boston, MA Jun 2011 A.S. in Business Administration, Accounting Option
Nov 2012 to 2000 AssociateBunker Hill Community College Boston, MA Jan 2011 to May 2011 Volunteer Income Tax Assistant
Education:
Bunker Hill Community College Boston, MA 2011 to 2012 A.S. in Business Administration, Finance OptionBunker Hill Community College Boston, MA 2009 to 2011 A.S. in Business Administration, Accounting Option
Skills:
Knowledge of Microsoft Word, PowerPoint, and Peach Tree. Excel(VLookup & Sort function), able to type 45wpm
Name / Title
Company / Classification
Phones & Addresses
Lily Li CFO
KINJAC ESTATES HOMEOWNERS ASSOCIATION, INC
PO Box 965523, Marietta, GA 30066 2565 Naz Ct, Marietta, GA 30066
Lily Li CFO
ACUPUNCTURE & ORIENTAL HEALTHCARE, INC
3325 Chamblee Dunwoody Rd, Atlanta, GA 30341
Lily Li Li Acupuncture
Oriental Health Care Center In Health Practitioner's Office
3325 Chamblee Dunwoody Rd, Atlanta, GA 30341
Lily Li Manager
China Plaza, Inc Eating Place Drinking Place
35 Market St, Rockland, MA 02370 7818787183
Lily Li CFO
CHINESE ACUPUNCTURISTS ASSOCIATION OF GEORGIA, INC
3325 Chamblee Dunwoody Rd, Atlanta, GA 30341
Us Patents
Generation Of Efficacy, Toxicity And Disease Signatures And Methods Of Use Thereof
Roger Wiegand - Wayland MA, US Robert McCarroll - Lexington MA, US Lily Li - Lexington MA, US Dong Wei - Malden MA, US Merce Crosas - Lexington MA, US James Rogers - Hingham MA, US Alexander Rosenberg - Brookline MA, US
International Classification:
C12Q001/00
US Classification:
435/004000
Abstract:
The invention provides methods of generating small molecule efficacy profiles and signature, small molecule toxicity profiles and signatures and small molecule disease profiles and signatures. The invention also provides methods of determining the efficacy and/or toxicity of unknown agents and drugs in a subject and methods of diagnosing an unknown disease or disorder in a subject. The invention further provides methods of monitoring the progression or remission of a disease or disorder in a subject undergoing treatment and methods of measuring the effectiveness of treatment.
The present invention relates to assays and methods for the detection of transthyretin and its isoforms. Specifically, the assays and methods of the present invention embrace liquid chromatography and mass spectrometry. The present invention also relates to unique peptides and peptide variants useful in the assays and methods.
- Cambridge MA, US Renta Hutabarat - Cambridge MA, US Rene Alvarez - Cambridge MA, US Bob Xiong - Cambridge MA, US Lily Y.T. Li - Cambridge MA, US
International Classification:
G01N 33/78 G01N 30/72
Abstract:
The present invention relates to assays and methods for the detection of transthyretin and its isoforms. Specifically, the assays and methods of the present invention embrace liquid chromatography and mass spectrometry. The present invention also relates to unique peptides and peptide variants useful in the assays and methods.
- Cambridge MA, US Renta Hutabarat - Cambridge MA, US Rene Alvarez - Cambridge MA, US Bob Xiong - Cambridge MA, US Lily Y.T. Li - Cambridge MA, US
International Classification:
G01N 33/78 C07K 14/575 G01N 33/58 C12Q 1/37
US Classification:
435 23, 530300, 530326, 530327
Abstract:
The present invention relates to assays and methods for the detection of transthyretin and its isoforms. Specifically, the assays and methods of the present invention embrace liquid chromatography and mass spectrometry. The present invention also relates to unique peptides and peptide variants useful in the assays and methods.